Lexicon Pharmaceuticals Inc (LXRX)

Finanzdaten der Lexicon Pharmaceuticals Inc-Aktie (LXRX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	60.97% 1.13	0.702	0.162	0.317	-62.31
Cost Of Revenue	55.71% 0.031	0.07	0.007	0.008	-
Gross Profit	73.89% 1.099	0.632	0.155	0.309	0.023
Operating Expenses	1.98% 46.43	47.37	49.79	44.55	-31.17
Benefits Costs and Expenses	2.06% 46.46	47.44	49.79	44.56	-30.37
Costs And Expenses	2.06% 46.46	47.44	49.79	44.56	-31.17
Operating Income/Loss	3.00% -45.33	-46.74	-49.63	-44.24	-31.14
Income/Loss From Continuing Operations Before Tax	3.00% -45.33	-46.74	-49.63	-44.90	-31.93
Income/Loss From Continuing Operations After Tax	2.73% -48.40	-49.76	-50.52	-44.90	-31.93
Net Income/Loss	2.73% -48.40	-49.76	-50.52	-44.90	-31.93
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,960% 245.39	8.018	244.93	204.78	189.01
Diluted Average Shares	2,960% 245.39	8.018	244.93	-	-
Basic Earnings Per Share	0.00% -0.20	-0.20	-0.21	-0.22	-0.17
Diluted Earnings Per Share	0.00% -0.20	-0.20	-0.21	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-